SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-23-000065
Filing Date
2023-06-05
Accepted
2023-06-05 08:43:53
Documents
18
Period of Report
2023-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20230604.htm   iXBRL 8-K 38175
2 EX-99.1 a2023_prx0604xasco-poste.htm EX-99.1 15332
7 a2023_prx0604xasco-poste001.jpg GRAPHIC 229884
8 a2023_prx0604xasco-poste002.jpg GRAPHIC 245001
9 a2023_prx0604xasco-poste003.jpg GRAPHIC 211379
10 a2023_prx0604xasco-poste004.jpg GRAPHIC 223127
  Complete submission text file 0001599298-23-000065.txt   1483038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20230604.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20230604_def.xml EX-101.DEF 15283
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20230604_lab.xml EX-101.LAB 29621
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20230604_pre.xml EX-101.PRE 15940
12 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20230604_htm.xml XML 11117
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 23991344
SIC: 2834 Pharmaceutical Preparations